Rain Oncology Inc. Common Stock
RAIN
RAIN was delisted on the 25th of January, 2024.
41 hedge funds and large institutions have $195M invested in Rain Oncology Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 7 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.27% less ownership
Funds ownership: 81.19% → 80.92% (-0.27%)
7% less funds holding
Funds holding: 44 → 41 (-3)
14% less capital invested
Capital invested by funds: $227M → $195M (-$31.5M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.26M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.67M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$725K |
| 4 |
State Street
Boston,
Massachusetts
|
+$322K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$267K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$3.15M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.73M |
| 3 |
Janus Henderson Group
London,
|
-$2.45M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$766K |
| 5 |
PA
Perceptive Advisors
New York
|
-$763K |
RAIN Hedge Fund Activity: Q4 2021 in Review
41 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q4 2021, worth a combined $195M — down 14% from $227M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of RAIN and 4 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 20 added.
The largest buyer was BlackRock, adding an estimated $5.26M. The largest seller was Logos Global Management, cutting an estimated $3.15M.
- 41 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q4 2021, down from 44 in Q3 2021.
- Funds reported $195M of Rain Oncology Inc. Common Stock stock for Q4 2021, down 14% quarter-over-quarter.
- 4 funds opened new Rain Oncology Inc. Common Stock positions in Q4 2021 and 7 closed out, a net change of -3 holders.
- The largest Rain Oncology Inc. Common Stock buyer in Q4 2021 was BlackRock, an estimated $5.26M added.
- The largest Rain Oncology Inc. Common Stock seller in Q4 2021 was Logos Global Management, an estimated $3.15M sold.
Based on aggregated 13F filings for Q4 2021.